{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:30:46Z","timestamp":1787729446381,"version":"build-2784847793"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T00:00:00Z","timestamp":1367280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1038\/nrneph.2013.83","type":"journal-article","created":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T05:31:42Z","timestamp":1367299902000},"page":"314-316","source":"Crossref","is-referenced-by-count":6,"title":["How effective and safe are antiplatelet agents in CKD?"],"prefix":"10.1038","volume":"9","author":[{"given":"J\u00fcrgen","family":"Floege","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Schlieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,30]]},"reference":[{"key":"BFnrneph201383_CR1","doi-asserted-by":"publisher","unstructured":"Palmer, S. C.  et al. Antiplatelet agents for chronic kidney disease. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD008834. \n                    http:\/\/dx.doi.org\/10.1002\/14651858.CD008834.pub2\n                    \n                  .","DOI":"10.1002\/14651858.CD008834.pub2"},{"key":"BFnrneph201383_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1053\/j.ajkd.2012.08.031","volume":"61","author":"SC Palmer","year":"2013","unstructured":"Palmer, S. C.  et al. Antiplatelet therapy to prevent hemodialysis vascular access failure: systematic review and meta-analysis. Am. J. Kidney Dis. 61, 112\u2013122 (2013).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201383_CR3","doi-asserted-by":"publisher","unstructured":"Kahn, M. R., Robbins, M. J., Kim, M. C. & Fuster, V. Management of cardiovascular disease in patients with kidney disease. Nat. Rev. Cardiol. \n                    http:\/\/dx.doi.org\/10.1038\/nrcardio.2013.15\n                    \n                  .","DOI":"10.1038\/nrcardio.2013.15"},{"key":"BFnrneph201383_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1056\/NEJMoa043545","volume":"353","author":"C Wanner","year":"2005","unstructured":"Wanner, C.  et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N. Engl. J. Med. 353, 238\u2013248 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201383_CR5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.7326\/0003-4819-137-7-200210010-00007","volume":"137","author":"RS Wright","year":"2002","unstructured":"Wright, R. S.  et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann. Intern. Med. 137, 563\u2013570 (2002).","journal-title":"Ann. Intern. Med."},{"key":"BFnrneph201383_CR6","unstructured":"Shroff, G. R., Li, S. & Herzog, C. A. Survival of US dialysis patients after acute myocardial infarction: is it finally getting better in the modern treatment era? [abstract]. Presented at the 2012 American Heart Association Scientific Sessions."},{"key":"BFnrneph201383_CR7","unstructured":"U. S. Renal Data System. USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States. National Institutes of Health, Bethesda, 2012."},{"key":"BFnrneph201383_CR8","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.2215\/CJN.00810209","volume":"4","author":"S Hiremath","year":"2009","unstructured":"Hiremath, S., Holden, R. M., Fergusson, D. & Zimmerman, D. L. Antiplatelet medications in hemodialysis patients: a systematic review of bleeding rates. Clin. J. Am. Soc. Nephrol. 4, 1347\u20131355 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201383_CR9","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters, R.  et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138, 1093\u20131100 (2010).","journal-title":"Chest"},{"key":"BFnrneph201383_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ki.2009.126","volume":"76","author":"T Krueger","year":"2009","unstructured":"Krueger, T., Westenfeld, R., Ketteler, M., Schurgers, L. J. & Floege, J. Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification? Kidney Int. 76, 18\u201322 (2009).","journal-title":"Kidney Int."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.83","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:42:58Z","timestamp":1684471378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2013.83"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,30]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["BFnrneph201383"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2013.83","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,30]]}}}